Huanyi Bio
焕一生物
Huanyi Bio (焕一生物, also known as AliveX Biotech) is a Chinese biotech company applying AI and systems immunology to drug development. In December 2020, the company raised an angel round of tens of millions of RMB led by 5Y Capital, with Xinyuan Capital participating . 5Y Capital has since featured Huanyi Bio as one of its key portfolio companies in the "ITBT" (IT + biotechnology) sector, alongside firms like Weizhijun (未知君) and Chen'an Bio (宸安生物) . The company's founder and CEO is Wen Wen (文雯), who has represented Huanyi Bio at 5Y Capital forums on digital pharmaceutical R&D alongside other portfolio company founders .
AI-generated — may contain errors, please verify.
Coverage
July: Seeking Vast Possibilities | 5Y News Monthly
The big news from last month.
五源资本·From Tech to Business: New Possibilities Brought by ITBT | 5Y Talk
We spoke with five entrepreneurs about their progress and breakthroughs.
五源资本·5Y Talk | Next-Gen Computing + Experimentation: The Birth of New Application Categories
Technology, Industry, and the Future.
五源资本·5Y Capital's Xu Tian Jing: Why We're Bullish on Digital Pharmaceutical R&D | 5Y Talk
The ITBT track has a promising future ahead.
五源资本·5Y News｜Vivace Therapeutics Announces Completion of Angel Round Raising Tens of Millions of RMB
Huanyi Bio announced the completion of an angel funding round of tens of millions of RMB, led by 5Y Capital.
五源资本·
